Skip to main content

Peer Review reports

From: Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial

Original Submission
1 Jul 2020 Submitted Original manuscript
2 Jul 2020 Reviewed Reviewer Report - Kirsty Loudon
Resubmission - Version 2
Submitted Manuscript version 2
Publishing
7 Jul 2020 Editorially accepted
9 Sep 2020 Article published 10.1186/s13063-020-04588-5

You can find further information about peer review here.

Back to article page

Trials

ISSN: 1745-6215